Effect of magnolol on the function of osteoblastic MC3T3-E1 cells

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Kwak, Eun Jung ^a   Lee, Young Soon ^b   Choi, Eun Mi ^b  

^a Yeungnam University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIMYCIN A1; COLLAGEN; GLUTATHIONE; INTERLEUKIN 6; MAGNOLOL; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; BIPHENYL DERIVATIVE; CYTOKINE; LIGNAN;

ANIMAL CELL; ARTICLE; BONE TURNOVER; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL STIMULATION; COLLAGEN SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; MAGNOLIACEAE; MINERALIZATION; MITOCHONDRION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; ANIMAL; CELL LINE; METABOLISM;

MAGNOLIA OFFICINALIS;

ALKALINE PHOSPHATASE; ANIMALS; ANTIMYCIN A; BIPHENYL COMPOUNDS; CELL LINE; COLLAGEN; CYTOKINES; GLUTATHIONE; INTERLEUKIN-6; LIGNANS; MICE; OSTEOBLASTS; RANK LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84858144129     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/829650     Document Type: Article

References (37)

1. Karsenty G., Wagner E. F., Reaching a genetic and molecular understanding of skeletal development Developmental Cell 2002 2 4 389 406 (Pubitemid 34436569)
2. Manolagas S. C., The role of IL-6 type cytokines and their receptors in bone a Annals of the New York Academy of Sciences 1998 840 194 204
3. Teitelbaum S. L., Bone resorption by osteoclasts Science 2000 289 5484 1504 1508
4. Wang J. P., Hsu M. F., Raung S. L., Chen C. C., Kuo J. S., Teng C. M., Anti-inflammatory and analgesic effects of magnolol Naunyn-Schmiedeberg's Archives of Pharmacology 1992 346 6 707 712
5. Teng C. M., Yu S. M., Chen C. C., Huang Y. L., Huang T. F., EDRF-release and Ca 2+ -channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta Life Sciences 1990 47 13 1153 1161
6. Fujita S., Taira J., Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102 Free Radical Biology and Medicine 1994 17 3 273 277 (Pubitemid 24269680)
7. Wang J. P., Lin P. L., Hsu M. F., Chen C. C., Possible involvement of protein kinase C inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat Journal of Pharmacy and Pharmacology 1998 50 10 1167 1172 (Pubitemid 28488137)
8. Wang J. P., Hsu M. F., Raung S. L., Chang L. C., Tsao L. T., Lin P. L., Chen C. C., Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils Journal of Pharmacy and Pharmacology 1999 51 3 285 294 (Pubitemid 29192782)
9. Chen Y. H., Lin S. J., Chen J. W., Ku H. H., Chen Y. L., Magnolol attenuates VCAM-1 expression in vitro in TNF- -treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits British Journal of Pharmacology 2002 135 1 37 47
10. Matsuda H., Kageura T., Oda M., Morikawa T., Sakamoto Y., Yoshikawa M., Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages Chemical and Pharmaceutical Bulletin 2001 49 6 716 720 (Pubitemid 32587118)
11. Kong C. W., Tsai K., Chin J. H., Chan W. L., Hong C. Y., Magnolol attenuates peroxidative damage and improves survival of rats with sepsis Shock 2000 13 1 24 28
12. Shih H. C., Wei Y. H., Lee C. H., Magnolol alters the course of endotoxin tolerance and provides early protection against endotoxin challenge following sublethal hemorrhage in rats Shock 2004 22 4 358 363
13. Ou H. C., Chou F. P., Sheu W. H. H., Hsu S. L., Lee W. J., Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells Archives of Toxicology 2007 81 6 421 432
14. Lee Y. S., Choi E. M., Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells Cellular Immunology 2011 270 2 224 229
15. Quarles L. D., Yohay D. A., Lever L. W., Caton R., Wenstrup R. J., Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development Journal of Bone and Mineral Research 1992 7 6 683 692
16. Bellows C. G., Aubin J. E., Heersche J. N. M., Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate Bone and Mineral 1991 14 1 27 40
17. Logan R. A., The role of osteoblasts and osteoclasts in osteogenesis American Journal of Orthodontics and Oral Surgery 1942 28 9 561 566
18. Burnstone M. S., Histochemical observations on enzymatic processes in bones and teeth Annals of the New York Academy of Sciences 1960 85 431 444
19. Lian J. B., Stein G. S., Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation Critical Reviews in Oral Biology and Medicine 1992 3 3 269 305
20. Sendur O. F., Turan Y., Tastaban E., Serter M., Antioxidant status in patients with osteoporosis: a controlled study Joint Bone Spine 2009 76 5 514 518
21. Abdallah B. M., Haack-Srensen M., Fink T., Kassem M., Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females Bone 2006 39 1 181 188 (Pubitemid 43831783)
22. Jiang S. Y., Shu R., Xie Y. F., Zhang S. Y., Age-related changes in biological characteristics of human alveolar osteoblasts Cell Proliferation 2010 43 5 464 470
23. Maggio D., Barabani M., Pierandrei M., Polidori M. C., Catani M., Mecocci P., Senin U., Pacifici R., Cherubini A., Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study Journal of Clinical Endocrinology and Metabolism 2003 88 4 1523 1527 (Pubitemid 36623364)
24. Altindag O., Erel O., Soran N., Celik H., Selek S., Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis Rheumatology International 2008 28 4 317 321
25. Ning J., Grant M. H., The role of reduced glutathione and glutathione reductase in the cytotoxicity of chromium (VI) in osteoblasts Toxicology in Vitro 2000 14 4 329 335 (Pubitemid 30440600)
26. Chiarugi P., Taddei M. L., Schiavone N., Papucci L., Giannoni E., Fiaschi T., Capaccioli S., Raugei G., Ramponi G., LMW-PTP is a positive regulator of tumor onset and growth Oncogene 2004 23 22 3905 3914 (Pubitemid 38747919)
27. Chiarugi P., Fiaschi T., Taddei M. L., Talini D., Giannoni E., Raugei G., Ramponi G., Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation Journal of Biological Chemistry 2001 276 36 33478 33487
28. Lacey D. L., Timms E., Tan H. L., Kelley M. J., Dunstan C. R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y. X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W. J., Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 1998 93 2 165 176 (Pubitemid 28180851)
29. Jimi E., Akiyama S., Tsurukai T., Okahashi N., Kobayashi K., Udagawa N., Nishihara T., Takahashi N., Suda T., Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function Journal of Immunology 1999 163 1 434 442 (Pubitemid 29295871)
30. Jezek P., Hlavata L., Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism International Journal of Biochemistry and Cell Biology 2005 37 12 2478 2503 (Pubitemid 41400319)
31. Nishikawa T., Araki E., Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications Antioxidants and Redox Signaling 2007 9 3 343 353 (Pubitemid 46150966)
32. Han Y. H., Park W. H., Growth inhibition in antimycin A treated-lung cancer Calu-6 cells via inducing a G1 phase arrest and apoptosis Lung Cancer 2009 65 2 150 160
33. Dong L., Xia S., Gao F., Zhang D., Chen J., Zhang J., 3,3′-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis Biochemical Pharmacology 2010 79 5 715 721
34. Gilbert L., He X., Farmer P., Rubin J., Drissi H., Van Wijnen A. J., Lian J. B., Stein G. S., Nanes M. S., Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2 A) is inhibited by tumor necrosis factor- Journal of Biological Chemistry 2002 277 4 2695 2701 (Pubitemid 34953297)
35. Kaneki H., Guo R., Chen D., Yao Z., Schwarz E. M., Zhang Y. E., Boyce B. F., Xing L., Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts Journal of Biological Chemistry 2006 281 7 4326 4333 (Pubitemid 43847863)
36. Hughes F. J., Howells G. L., Interleukin-6 inhibits bone formation in vitro Bone and Mineral 1993 21 1 21 28 (Pubitemid 23161155)
37. Fang M. A., Hahn T. J., Effects of interleukin-6 on cellular function in UMR-106-01 osteoblastlike cells Journal of Bone and Mineral Research 1991 6 2 133 139